Literature DB >> 19930907

Mechanisms of therapeutic effects of rhubarb on gut origin sepsis.

De-chang Chen1, Lü Wang.   

Abstract

It is proposed that gut-liver-lung axis plays an important role in the pathophysiologic development of the critical illness, and it induces excessive inflammatory response in vivo and multiple organ dysfunction syndrome. The mechanisms of therapeutic effects of rhubarb on critical patients are studied based on the theory of Chinese traditional medicine. Researches demonstrate that rhubarb can be used to protect gut barrier, maintain intestinal micro-ecological environment and prevent bacterial translocation. It also can be used to inhibit the release of inflammatory mediators by liver inflammatory-effector cells, reduce inflammatory reaction in the liver and protect hepatic cell functions. Furthermore, rhubarb can be used to reduce pulmonary vascular permeability and extenuate pulmonary edema, inhibit the release of neutrophil myeloperoxidase, and lower the level of inflammatory response and decrease inflammatory mediators in circulation. The above results indicate that rhubarb may interrupt or partly interrupt the gut-liver-lung axis after trauma and reduce the intensity of systemic inflammatory response syndrome. Therefore, rhubarb may obviously lower the incidence of multiple organ dysfunction syndrome and be used to prevent and treat systemic inflammatory response syndrome and multiple organ dysfunction syndrome after trauma.

Entities:  

Mesh:

Year:  2009        PMID: 19930907

Source DB:  PubMed          Journal:  Chin J Traumatol        ISSN: 1008-1275


  18 in total

1.  Effects of L-canavanine and ozone on vascular reactivity in septicemic rats.

Authors:  Mohamed A Haidara; Mohamed D Morsy; Hesham A Abdel-Razek; Dimitri P Mikhailidis; Esma R Isenovic
Journal:  J Physiol Biochem       Date:  2010-07-22       Impact factor: 4.158

2.  Optimized extraction process and identification of antibacterial substances from Rhubarb against aquatic pathogenic Vibrio harveyi.

Authors:  Lei Guo; Jiacai Guo; Fuquan Xu
Journal:  3 Biotech       Date:  2017-10-23       Impact factor: 2.406

3.  Rhubarb vs. glycerin enema for treatment of critically ill patients with intra-abdominal hypertension.

Authors:  Bing Wan; Hao Zhang; Jiangtao Yin; Haiyan Fu; Yikun Chen; Liping Yang; Dadong Liu; Tangfeng Lv; Yong Song
Journal:  Exp Ther Med       Date:  2017-06-07       Impact factor: 2.447

Review 4.  Alternative Treatments for Minor GI Ailments.

Authors:  A K Mohiuddin
Journal:  Innov Pharm       Date:  2019-07-05

5.  Rhubarb Antagonizes Matrix Metalloproteinase-9-induced Vascular Endothelial Permeability.

Authors:  Yun-Liang Cui; Sheng Zhang; Zhao-Tao Tian; Zhao-Fen Lin; De-Chang Chen
Journal:  Chin Med J (Engl)       Date:  2016-07-20       Impact factor: 2.628

6.  Rhubarb Monomers Protect Intestinal Mucosal Barrier in Sepsis via Junction Proteins.

Authors:  Lyu Wang; Yun-Liang Cui; Zhe Zhang; Zhao-Fen Lin; De-Chang Chen
Journal:  Chin Med J (Engl)       Date:  2017-05-20       Impact factor: 2.628

7.  Sepsis and Intestinal Microvascular Endothelial Dysfunction.

Authors:  De-Chang Chen
Journal:  Chin Med J (Engl)       Date:  2017-05-20       Impact factor: 2.628

8.  Electroacupuncture at Bilateral Zusanli Points (ST36) Protects Intestinal Mucosal Immune Barrier in Sepsis.

Authors:  Mei-Fei Zhu; Xi Xing; Shu Lei; Jian-Nong Wu; Ling-Cong Wang; Li-Quan Huang; Rong-Lin Jiang
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-04       Impact factor: 2.629

9.  Association between TLR4 and PTEN Involved in LPS-TLR4 Signaling Response.

Authors:  Huahua Yin; Yan Tan; Xiaofeng Wu; Hong Yan; Feng Liu; Yuanzhang Yao; Jianxin Jiang; Qi Wan; Lei Li
Journal:  Biomed Res Int       Date:  2016-08-02       Impact factor: 3.411

10.  Network Pharmacology-Based Approach to Investigate the Molecular Targets of Rhubarb for Treating Cancer.

Authors:  Lan Jiang; Zhongquan Shi; Yi Yang
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-08       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.